What is BioQ Pharma?
BioQ Pharma operates as a commercial-stage enterprise dedicated to the modernization of infusible medicine administration. The company specializes in developing proprietary, pre-filled, and adaptable delivery systems designed to simplify the dosing process for healthcare providers and patients alike. By addressing the inherent challenges associated with hard-to-administer drugs, BioQ Pharma provides a value-driven solution that prioritizes safety, precision, and operational efficiency. Their technology platform is engineered to integrate seamlessly into existing clinical workflows, effectively bridging the gap between complex pharmaceutical formulations and user-friendly administration. As a key player in the medical device and drug delivery space, the company remains focused on delivering high-impact solutions that improve therapeutic outcomes while reducing the administrative burden on the healthcare system.
How much funding has BioQ Pharma raised?
BioQ Pharma has raised a total of $53.7M across 5 funding rounds:
Debt
$13.7M
Private Equity
$18.3M
Debt
$15M
Private Equity
$6.3M
Debt
$350K
Debt (2014): $13.7M, investors not publicly disclosed
Private Equity (2015): $18.3M, investors not publicly disclosed
Debt (2016): $15M, investors not publicly disclosed
Private Equity (2017): $6.3M, investors not publicly disclosed
Debt (2020): $350K backed by PPP
Key Investors in BioQ Pharma
PPP
Public-Private Partnership
Undisclosed Investor
An institutional participant in the company's private equity rounds, focusing on high-growth medical technology ventures.
Undisclosed Investor
A strategic backer providing capital to support the development and market adoption of proprietary drug delivery systems.
What's next for BioQ Pharma?
With the recent infusion of capital, BioQ Pharma is well-positioned to accelerate the commercial deployment of its delivery systems. The strategic roadmap likely involves scaling manufacturing capabilities to meet increasing demand and further diversifying its pipeline of pre-filled, ready-to-use solutions. As the company transitions into a more mature phase of its lifecycle, the focus will shift toward deepening market penetration and establishing long-term partnerships with pharmaceutical manufacturers and healthcare providers. Continued investment in research and development will be essential to maintaining its competitive edge in the rapidly evolving landscape of medical technology and drug delivery innovation.
See full BioQ Pharma company page
